In a clinical cohort of consecutive and unselected HIV mono-infected patients without known liver disease, we ascertained the prevalence and predictors of NASH diagnosed by combining CK-18 and TE with CAP. This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatohepatitis.